ESSENCE

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease - The New England Journal of Medicine - 1997

Brief Summary:

Enoxaparin reduces the composite endpoint of death, MI, or recurrent angina at 14 days when compared to unfractionated heparin in the treatment of UA/NSTEMI.

Reference:
http://www.ncbi.nlm.nih.gov/pubmed/9250846